Neuralstem is a biopharmaceutical company out of Rockville, Maryland, that specializes in the development and commercialization of treatments for diseases related to the central nervous system. Its innovative technology allows for the isolation of human stem cells to enable generation of new neurons. Several of its products have successfully completed Phase 1 clinical trials. For more information, please visit the company’s website at www.neuralstem.com